NSEGeneral Updates7 Sept 2026 · 7 Sept 2026, 06:59 pm

General Updates

Panacea Biotec Limited · PANACEABIO

✦ AI Summary

Panacea Biotec Limited has informed the Exchange about General Updates - Confirmation on letter being sent to the concerned shareholders providing the weblink for accessing the Annual Report for financial year 2025-26 and the Notice of the ensuing AGM, to be held on September 29, 2026, through Video Conferencing / Other Audio-Visual Means.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Panacea Biotec Limited has informed the Exchange about General Updates - Confirmation on letter being sent to the concerned shareholders providing the weblink for accessing the Annual Report for financial year 2025-26 and the Notice of the ensuing AGM, to be held on September 29, 2026, through Video Conferencing / Other Audio-Visual Means.

Attachments (1)

📄

PANACEABIO_07092026185857_IntimationForWebLinkLettersToShareholders.pdf

pdf

Download →
View document text
September 07, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051 Dalal Street, Mumbai - 400 001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349 Reg.: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, We would like to inform you that pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the enclosed letter is being sent to the shareholders whose e-mail addresses are not registered with the Company / Depository Participants, providing the weblink for accessing the Annual Report of the Company for the financial year 2025-26 and the Notice of the ensuing Annual General Meeting, to be held on September 29, 2026 through Video Conferencing / Other Audio-Visual Means. We request you to take the above on record. Thanking you, Sincerely yours, For Panacea Biotec Limited Ankit Jain General Manager - Legal & Company Secretary Encl.: As Above Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com Dated: September 07, 2026 Dear Shareholder, Sub.: Web-Link of Notice of 42nd Annual General Meeting and Annual Report for Financial Year 2025-26 Dear Shareholder, We are pleased to inform you that the 42nd Annual General Meeting (“AGM”) of Panacea Biotec Limited (“the Company”) will be held on Tuesday, September 29, 2026, at 11:30 A.M (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) in compliance with the applicable circulars issued by Ministry of Corporate Affairs (“MCA”) and Securities and Exchange Board of India (“SEBI”). It may be further noted that the Notice of the 42nd AGM along with the Annual Report for the Financial Year ended March 31, 2026, have been sent to all the Members whose email addresses are registered with the Company / Depository Participant(s), only through electronic mode on Monday, September 07, 2026. In the absence of your email-ID being registered with the Depository Participant / Company’s Registrar and Transfer Agent (“RTA”), please find below web-link to access Notice of AGM, inter-alia, indicating the process and manner of e-voting and Annual Report for the Financial Year ended March 31, 2026, in accordance with Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice of AGM: https://www.panaceabiotec.com/en/section/information-repository/agm-notice Annual Report:https://www.panaceabiotec.com/en/section/information-repository/annual-report The remote e-Voting facility would be available during the following period: Cut-off date for remote e-voting September 22, 2026 Remote e-Voting start date From 09.00 a.m. (IST) on September 26, 2026 Remote e-voting end date Upto 05.00 p.m. (IST) on September 28, 2026 Manner of registering / updating e-mail addresses and other KYC details: In order to receive communications from the Company promptly, we request you to immediately register your email address by following below steps: • in case shares are held in electronic form - with your Depository Participant; and • in case shares are held in physical form - with the Company’s RTA, by submitting hard copies of duly filled-in, signed and attested form ISR-1 and form ISR-2 (if required), at its address given below: Skyline Financial Services Private Limited (Unit: Panacea Biotec Limited) D-153A, 1st Floor, Okhla Industrial Area, Phase-I, New Delhi-110020 Email: kyc@skylinerta.com; Phone No. 011-40450193-97 We look forward to your participation in the ensuing AGM of your Company. Thanking You, Yours faithfully, For Panacea Biotec Limited Sd/- Ankit Jain General Manager - Legal & Company Secretary Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com